RUTIGLIANO, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 3.094
AS - Asia 1.251
EU - Europa 990
SA - Sud America 259
AF - Africa 39
AN - Antartide 1
OC - Oceania 1
Totale 5.635
Nazione #
US - Stati Uniti d'America 3.038
SG - Singapore 529
CN - Cina 335
IT - Italia 255
BR - Brasile 225
SE - Svezia 194
RU - Federazione Russa 167
HK - Hong Kong 157
DE - Germania 110
VN - Vietnam 103
GB - Regno Unito 61
FI - Finlandia 59
CA - Canada 36
UA - Ucraina 36
FR - Francia 26
IN - India 24
NL - Olanda 24
ID - Indonesia 21
BE - Belgio 19
JP - Giappone 17
MX - Messico 16
CI - Costa d'Avorio 15
AR - Argentina 14
BD - Bangladesh 14
ZA - Sudafrica 11
TR - Turchia 10
ES - Italia 8
CO - Colombia 7
IR - Iran 6
SA - Arabia Saudita 6
IQ - Iraq 5
LT - Lituania 5
PK - Pakistan 5
VE - Venezuela 5
AT - Austria 4
KR - Corea 4
PL - Polonia 4
UZ - Uzbekistan 4
CL - Cile 3
EG - Egitto 3
IE - Irlanda 3
MA - Marocco 3
BY - Bielorussia 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MT - Malta 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
RE - Reunion 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 5.635
Città #
Ashburn 412
Fairfield 352
Singapore 299
Chandler 259
Woodbridge 249
Seattle 176
Houston 172
Hong Kong 156
Cambridge 145
Beijing 144
Nyköping 144
Wilmington 127
Ann Arbor 122
Bari 98
New York 75
Jacksonville 66
Los Angeles 63
Munich 54
Roxbury 42
Dallas 40
Lawrence 40
Ho Chi Minh City 36
Nanjing 29
Princeton 27
Des Moines 25
São Paulo 24
Brooklyn 23
Inglewood 23
Dearborn 20
Brussels 18
Buffalo 18
Hanoi 18
Toronto 18
Boardman 17
Jakarta 17
Chicago 16
Dong Ket 16
Santa Clara 16
Turku 16
Abidjan 15
London 14
Rome 13
Shenyang 13
Helsinki 12
San Diego 12
Manduria 11
Nanchang 11
The Dalles 11
Moscow 10
Tianjin 10
Changsha 9
Columbus 9
Hebei 9
Indianapolis 9
Mexico City 9
San Jose 9
Frankfurt am Main 8
Rio de Janeiro 8
Tokyo 8
Amsterdam 7
Boston 7
Brasília 7
Council Bluffs 7
Orem 7
Pune 7
Redwood City 7
San Francisco 7
Milan 6
Montreal 6
Paris 6
Phoenix 6
Atlanta 5
Augusta 5
Belo Horizonte 5
Bitonto 5
Catania 5
Chennai 5
Curitiba 5
Falkenstein 5
Guangzhou 5
Haiphong 5
Hefei 5
Jiaxing 5
Johannesburg 5
Kunming 5
Noicattaro 5
Nuremberg 5
Stockholm 5
Campinas 4
Caracas 4
Casamassima 4
Denver 4
Monmouth Junction 4
Naples 4
Nova Iguaçu 4
Ottawa 4
Piracicaba 4
San Mateo 4
Warsaw 4
Biên Hòa 3
Totale 4.034
Nome #
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 205
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 195
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 186
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 185
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 185
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 181
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 174
Isolation and characterization of cancer stem cells in renal cell carcinoma. 167
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 166
Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression 154
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 150
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 149
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 144
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 136
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 136
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 135
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 130
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 128
Emerging urinary markers of renal injury in obstructive nephropathy. 126
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 119
Cryopreserved Penile Tunica Albuginea for Allotransplantation: A Morphological and Ultrastructural Investigation. 115
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 112
Analisi dei fattori critici nello studio MALDI-TOF del profilo peptidico urinario in soggetti sani e con cancro alla prostata 110
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 107
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 105
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles 105
The Anti-Fibrotic Effect of Mycophenolic Acid-Induced Neutral Endopeptidase 100
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 100
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 98
Regulation of TGF-beta 1 expression by Androgen Deprivation Therapy of prostate cancer 88
ASSOCIATION OF N-ACETYLTRANSFERASE 2 POLYMORPHISM WITH RISK FACTORS IN UROTHELIAL CANCER. 87
null 86
LAMININA 5 COME MARKER NELLA DIAGNOSI E NELLA PROGNOSI DEL CARCINOMA UROTELIALE DELLA VESCICA 85
RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS? 83
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 83
DIABETES MELLITUS IS A RISK FACTOR FOR PROGRESSION IN RENAL CELL CARCINOMA 81
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Insipidus 80
THE DIAGNOSTIC ROLE OF CA 15-3, CA 125 AND BETA2-MICROGLOBULIN IN RENAL CELL CARCINOMA 79
null 74
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation 70
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 69
CTR2 Identifies a Population of Cancer Cells with Stem-Like Features in Patients with Clear Cell Renal Cell Carcinoma. 69
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 66
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer 64
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets. 62
LOSS OF LKB1 EXPRESSION IS AN EARLY MOLECULAR EVENT IN PROSTATE CARCINOGENESIS 62
null 61
SP168 ARPCS CAN REVERT LPS-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION OF ENDOTHELIAL CELLS 53
To007 Adult Renal Stem/progenitor Cells Express Long Non-coding Rnas Involved In Wnt And The Bmp Signaling Pathway 52
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome 52
null 49
null 46
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma 42
The Role of MUC1 in Renal Cell Carcinoma. Biomolecules. 41
null 36
null 16
Totale 5.839
Categoria #
all - tutte 24.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021324 0 0 0 0 0 18 48 52 33 64 69 40
2021/2022375 22 30 8 13 18 26 23 19 20 50 65 81
2022/2023619 96 106 48 63 48 86 4 65 68 6 16 13
2023/2024242 22 40 10 18 27 86 6 5 2 9 6 11
2024/20251.188 30 22 69 59 36 98 190 120 44 67 155 298
2025/20261.300 408 122 114 206 320 130 0 0 0 0 0 0
Totale 5.839